DUBLIN, April 2, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it has agreed to extend a temporary stay of its litigation against the U.S. Food and Drug Administration (FDA). The litigation, filed in the U.S. District Court for the District of Columbia in...
from PR Newswire: //https://ift.tt/2GKzJmO
No comments:
Post a Comment